ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Sjögren’s Syndrome"

  • Abstract Number: 0037 • ACR Convergence 2020

    Lipoprotein-associated Phospholipase A2: A New Biomarker for Lymphoma Development in Sjögren’s Syndrome

    Adrianos Nezos1, Eleni Kotsifaki1, Charalampos Skarlis2, Konstantinos Markakis1, Haralampos Moutsopoulos3, Michael Koutsilieris1, Clio Mavragani1 and Anna Psarrou1, 1National & Kapodistrian University of Athens, Athens, Greece, 2National &Kapodistrian University of Athens, Athens, Greece, 3National & Kapodistrian University of Athens/ Academy of Athens, Athens, Greece

    Background/Purpose: B-cell non-Hodgkin's lymphoma (B-NHL) is one of the major complications of primary Sjögren’s syndrome (SS). Chronic inflammation and macrophages in SS minor salivary glands…
  • Abstract Number: 1253 • ACR Convergence 2020

    Re-evaluation of the Extent of Lymphocytic Infiltration May Improve the Diagnostic Accuracy of Lip Biopsy in Primary Sjögren’s Syndrome (pSS)

    Chiara Baldini1, Francesco Ferro1, Gianmaria Governato1, Giovanni Fulvio2, Elena Elefante3, Marta Mosca1, Stefano Bombardieri1 and Valentina Donati4, 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 2Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, 3Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa; Department of Medical Biotechnology, University of Siena, Pisa, Italy, 4Pathology Unit, AOUP, Pisa

    Background/Purpose: Focus score (FS) remains the key element for the histological diagnosis of pSS; nonetheless, additional parameters have been proposed for clinical trials including the…
  • Abstract Number: 0091 • ACR Convergence 2020

    Helicobacter Pylori Infection, Autoimmune Disease and Paraproteinemia Influence the Presentation of a Cohort of 150 Pernicious Anemia Patients Diagnosed in a Rheumatology Clinic

    Michael Lovy1, Norma Daniela Aguirre Vega1 and Crystal Escobar1, 1Desert Oasis Healthcare, Palm Springs, CA

    Background/Purpose: The most familiar presentation of pernicious anemia is an elderly Northern European woman with hematologic and neurologic manifestations.  More recently the influence of Helicobacter…
  • Abstract Number: 1254 • ACR Convergence 2020

    Lack of Efficacy of Early Treatment with Hydroxychloroquine in a Group of Hispanics with Primary Sjögren’s Syndrome

    Ariana González-Meléndez1, Patricia Jordán-González1, Ricardo Gago-Piñero1, Noemí Varela-Rosario1, Naydi Pérez-Ríos1 and Luis Vilá1, 1University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico

    Background/Purpose: Treatment of primary Sjögren’s syndrome (pSS) with hydroxychloroquine (HCQ) has been evaluated in the past but with conflicting results regarding its efficacy. While earlier…
  • Abstract Number: 0293 • ACR Convergence 2020

    Contraction of the Stool Taxa Clostridia Is Associated with the Development of Clinical Disease Among Anti-Ro+ Mothers of Children with Neonatal Lupus

    Robert Clancy1, Miranda Marion2, Peter Izmirly3, Mala Masson4, Hannah Ainsworth2, Timothy Howard5, Jill Buyon6 and Carl Langefeld7, 1NYU School of Medicine, New York, 2Wake Forest School of Medicine, Winston-Salem, 3Department of Medicine, New York University School of Medicine, New York, NY, 4New York University School of Medicine, New York, 5Wake Forest School of Medicine, Winston-Salem, NC, 6Department of Medicine, NYU School of Medicine, New York, NY, 7Wake Forest School of Medicine, Winston Salem, NC

    Background/Purpose: Anti-Ro autoantibody production often precedes the development of systemic lupus erythematosus (SLE) or Sjögren’s syndrome (SS) by years. Anti-Ro+ mothers of children with manifestations…
  • Abstract Number: 1255 • ACR Convergence 2020

    Sjӧgren’s Syndrome Minor Salivary Gland Mesenchymal Stromal Cells Derived Deploy Intact Immune Plasticity and Display Myofibroblast-Like Properties

    Sara McCoy1, Jayeeta Giri1, Rahul Das1, Pradyut Paul1, Andrea Pennati1, Maxwell Parker1, Yun Liang1 and Jacques Galipeau1, 1University of Wisconsin, Madison

    Background/Purpose: Primary Sjӧgren’s syndrome (pSS) is the second most common systemic autoimmune disease with hallmark features of severe ocular and oral sicca, leading to reduced…
  • Abstract Number: 0449 • ACR Convergence 2020

    Cytotoxic T Cells with a Chronic Antigen Exposure Phenotype Drive Immune Checkpoint Inhibitor Sicca

    Blake Warner1, Billel Gasmi2, David Kleiner3, Paola Perez Riveros4, Daniel Barber5, Shunsuke Sakai5 and Alan Baer6, 1National Institute of Dental and Craniofacial Research, Bethesda, 2National Cancer Institute, Bethesda, MD, 3National Cancer Institute, Bethesda, 4National Institute of Dental and Craniofacial Research, Bethesda, MD, 5National Institute of Allergy and Infectious Disease, Bethesda, MD, 6Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Immune checkpoint inhibitors (ICI) have advanced the field of cancer therapeutics. By blocking the negative co-stimulation of T cells, ICI augment the anti-tumor immune…
  • Abstract Number: 1256 • ACR Convergence 2020

    Mast Cells Contribute to the Development of Sialadenitis Associated with Sjögren’s Syndrome via Inducing Tissue Fibrosis by TGFβ Production

    Shinjiro Kaieda1, Kyoko Fujimoto1 and Hiroaki Ida1, 1Kurume University School of Medicine, Kurume, Japan

    Background/Purpose: Mast cells have been implicated in many immune-inflammatory disorders. They mediate a variety of inflammatory and fibrotic conditions, but their role in sialadenitis in…
  • Abstract Number: 0997 • ACR Convergence 2020

    Novel Shared Antibody Specificities in Ro Antibody Negative Sjögren’s Syndrome

    Sherri Longobardi1, Constantin Georgescu2, Christina Lawrence3, Charmaine Moya3, Jonathan Wren4, Judith James5, Kathy Sivils3 and A. Darise Farris6, 1Graduate Program in Biological Sciences, University of Oklahoma Health Sciences Center; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, 5Oklahoma Medical Research Foundation, Oklahoma City, 6Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City

    Background/Purpose: Sjögren’s syndrome (SS) is a rheumatic autoimmune disease characterized by focal lymphocytic infiltrates in the lacrimal and salivary glands, severe dry mouth and eyes,…
  • Abstract Number: 1409 • ACR Convergence 2020

    Lack of Conventional Acinar Cells in the Salivary Gland Following Anti PD-L1 and anti-PD-1 Immune Checkpoint Inhibitor Therapy

    Sarah Pringle1, Bert van der Vegt1, Xiaoyan Wang1, Nico van Bakelen1, Arjan Vissink1, Frans Kroese2 and Hendrika Bootsma2, 1UMCG, Groningen, 2University Medical Centre Groningen, Groningen, Netherlands

    Background/Purpose: Salivary glands (SGs) can be damaged by immune checkpoint inhibitor (ICI) therapy. In patients with ICI-induced SG dysfunction, 60% progress to fulfill the ACR-EULAR…
  • Abstract Number: 1242 • ACR Convergence 2020

    Transcranial Direct Current Stimulation for Fatigue in Patients with Sjogren’s Syndrome: A Randomized, Double-blind Pilot Study

    Ana Pinto1, Sara Piva2, Alexia Vieira3, Samantha Gomes3, Aline Rocha4, Daniela Tavares3, Marcia Santana3, Cristiane Carlesso5, Adagmar Andriolo3, Fania Santos6, Felipe Fregni7 and Virginia Trevisani3, 1Universidade Federal do Amapa, Sao Paulo, Brazil, 2Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA, 3Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 4Universidade Federal de Sao Paulo, Sao Paulo, Sao Paulo, Brazil, 5University of Pittsburgh, Pittsburgh, 6Universidade Federal de Sao Paulo, Sao Paulo, Saint Helena, 7Harvard Medical School, Cambridge, MA

    Background/Purpose: Transcranial direct-current stimulation (tDCS) has shown promise to decrease fatigue. However, it has never been examined in primary Sjogren Syndrome (pSS). We aimed to assess…
  • Abstract Number: 1502 • ACR Convergence 2020

    Composite of Relevant Endpoints for Sjögren’s Syndrome (CRESS)

    Suzanne Arends1, Liseth de Wolff2, Jolien van Nimwegen3, Gwenny Verstappen2, Jelle Vehof2, Arjan Vissink4, Neelanjana Ray5, Frans Kroese2 and Hendrika Bootsma2, 1University Medical Centre Groningen and Medical centre Leeuwarden, Groningen, Netherlands, 2University Medical Centre Groningen, Groningen, Netherlands, 3University Medical Center Groningen, Groningen, Netherlands, 4University Medical Centre Groningen, Leek, Netherlands, 5Bristol-Myers Squibb, Lawrenceville

    Background/Purpose: Several recent randomized controlled trials that used the validated ESSDAI as primary endpoint failed, partly explained by relatively large response rates in the placebo…
  • Abstract Number: 1243 • ACR Convergence 2020

    Self-reported Fatigue in Patients with Primary Sjögren’s Syndrome Is Associated with an Objective Decline in Physical Performance and Symptoms of Pain and Depression

    Roeland Prak1, Suzanne Arends2, Greetje van Zuiden1, Frans Kroese1, Hendrika Bootsma1 and Inge Zijdewind1, 1University Medical Centre Groningen, Groningen, Netherlands, 2University Medical Centre Groningen and Medical centre Leeuwarden, Groningen, Netherlands

    Background/Purpose: Fatigue is a major complaint in autoimmune diseases including primary Sjögren’s syndrome (pSS). For many pSS patients, fatigue is their most dominant and disabling…
  • Abstract Number: 1503 • ACR Convergence 2020

    Ultra High‐resolution Ultrasound (UHFUS) of Labial Salivary Glands Might Help to Avoid Unnecessary Lip Biopsy in Patients with Sicca Syndrome

    Chiara Baldini1, Francesco Ferro1, Rossana Izzetti2, Saverio Vitali3, Giacomo Aringhieri3, Silvia Fonzetti4, Marta Mosca1, Valentina Donati5, Stefano Bombardieri1 and Davide Caramella3, 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 2Department of Surgical Pathology, Medicine, Molecular and Critical Area, University of Pisa, Pisa, Italy, Pisa, 3Diagnostic and Interventional Radiology, Department of Translational Research and of New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy, Pisa, 4Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, 5Pathology Unit, AOUP, Pisa

    Background/Purpose: Major salivary gland ultrasonography (SGUS) has an established role as a first-line imaging tool in the diagnosis of primary Sjögren’s syndrome (pSS). Nowadays, however,…
  • Abstract Number: 1244 • ACR Convergence 2020

    Clinical Characteristics and Outcomes in Patients with Primary Sjögren’s Syndrome-Associated Interstitial Lung Disease

    Joanna Marco1, Gregory Gardner1 and Nishant Gupta2, 1University of Washington, Seattle, WA, 2University of Cincinnati, Cincinnati

    Background/Purpose: Primary Sjögren’s syndrome (pSS) is a chronic autoimmune exocrinopathy that features interstitial lung disease (ILD) in up to 16% of patients. The clinical characteristics…
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology